Gene Query: TDP1

Dataset Description Geneva Score
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  24.37
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 19.29
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.79
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 15.01
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 14.38
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 14.3
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 13.04
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 12.4
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 12.4
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 11.65
RNAseq analysis of ESRP regulated splicing events in prostate cancer 11.57
Inhibition of TNBC metastasis by Gpx1 10.93
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 10.91
Genome-wide functional assessment of enhancer activities in the human genome 10.52
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 10.14
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 10.14
RNA-seq data from human lymphoma cell lines 10.06
ChIP-seq and RNA-seq from human lymphoma cell lines 10.06
METTL3 promotes translation in human cancer cells 9.81
LNCaP treated with iBET 9.35
Trans-differentiation of human adult peripheral blood T cells into neurons 9.06
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 9.06
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 9.02
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 8.88
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 8.44
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 8.4
Role for citron kinase in prostate cancer growth 8.39
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 8.33
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 8.21
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.83
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.83
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.45
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.38
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.38
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 7.25
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 7.09
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 7.08
Glioblastoma stem cells infected by ZIKA virus 7.02
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.01
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.01
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 6.86
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 6.86
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.76
Zika infected neural stem cells 6.74
Transcriptome analysis of Zika infected neural stem cells 6.74
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 6.6
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.56
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.53
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 6.52
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 6.22
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.21
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.08
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.08
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.03
RNA-seq of cells with TET1 knockout 6.02
Analysis of transcriptional regulation by Myt1 and Myt1l 5.99
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.68
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 5.67
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.67
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 5.63
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.61
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 5.57
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 5.48
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 5.48
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.41
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.41
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.38
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.34
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.3
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 5.25
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.25
Transcriptome-wide identification of CELF2 functional targets in T cells 5.24
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.21
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.21
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.17
Effect of from Human Umbilical Vein Endothelial Cells 5.12
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.11
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.05
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.05
Transcriptome analysis of H9 hESC derived cerebral organoids 4.97
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.97
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.97
Cerebellar differentiation in Ataxia-Telangiectasia 4.97
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.96
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.95
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.93
GATA3-mediated chromatin reprogramming in breast cancer cells 4.93
RNA-seq analysis of RALD iPSCs after in vitro differentiation 4.92
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 4.92
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 4.91
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 4.89
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.86
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.83
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.83
MYC dependent mRNA translation shapes gene expression and cell biology 4.81
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 4.76
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 4.74
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.73
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.73
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.71
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.67
Transcription control by the ENL YEATS domain in acute leukemia 4.67
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.67
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.67
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.63
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.61
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.61
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 4.59
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 4.59
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.58
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 4.52
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 4.52
Co-regulation of splicing by Rbfox1 and hnRNP M 4.48
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.48
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 4.48
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 4.47
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.46
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.45
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.42
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.38
The Human Testis Cell Atlas via Single-cell RNA-seq 4.37
The landscape of alternative splicing in aggressive prostate cancers 4.37
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.36
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.34
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.28
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.23
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.2
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 4.19
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.19
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.19
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.19
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.19
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.19
The role of FAM46C in myeloma cells [sequencing] 4.14
The role of FAM46C in myeloma cells 4.14
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 4.14
MeRIP-seq for heat shock in B-cell lymphoma cells 4.12
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 4.12
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.11
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 4.11
Identification of global regulators of T-helper cell lineage specification 4.11
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 4.04
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.01
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 3.99
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.91
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.91
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.9
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.9
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.89
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.89
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.88
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 3.87
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.85
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.85
Stem and effector CD8 T-cells from human cancers 3.84
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.83
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.83
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.83
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.81
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 3.81
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.79
Gene expression profile in breast cancer cells 3.79
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 3.79
SNHG5 siRNA knock down in HCT116 cells 3.77
Effect of CHKA knockdown on C4-2 cell transcriptome 3.76
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.73
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.73
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.7
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 3.69
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.65
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 3.65
A map of gene expression in neutrophil-like cell lines 3.65
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.64
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.64
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.63
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.63
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 3.58
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 3.58
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.57
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.54
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 3.52
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 3.48
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.48
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.48
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.47
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.47
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.45
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.45
MAIT cell RNA sequencing 3.45
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 3.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 3.45
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.42
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 3.42
TGF-β regulation of miRNA expression in pancreatic cancer 3.41
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.4
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.39
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 3.38
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.36
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 3.34
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.33
The conserved transcriptional landscapes in human spermatogenesis 3.33
Gene expression in PANC1 cells treated with Rakicidin 3.33
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 3.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.32
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.31
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.31
Comparison of microRNA Profiling Platforms 3.3
Comparison of microRNA Profiling Platforms (HTS) 3.3
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.3
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.29
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.28
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 3.27
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.26
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.24
Loss of CREBBP results in gene expression repression in lymphoma cells 3.24
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.24
Ribosomal footprinting of MDA-Parental and MDA-LM2 3.23
Seletive inhibition of CDK9 in DLBCL cell lines 3.22
Ribosomal footprinting of CN34-Parental and CN34-LM1a 3.22
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 3.21
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 3.21
A code of mono-phosphorylation modulates the function of RB. 3.2
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 3.2
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 3.19
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 3.18
Identification of global XBP1s target gene expression in human prostate cancer cells 3.14
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.12
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.11
UBC9 knockdown in bladder cancer T24 cell lines 3.1
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.1
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.1
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.1
N6-methyladenine DNA Modification in Glioblastoma 3.1
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 3.09
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 3.09
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 3.09
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.08
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.08
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 3.08
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.07
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.07
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.04
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.04
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.04
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 3.04
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.03
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 3.03
Gene expressions of H9s in different culture systems 3.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.01
Chromatin landscape of human visceral and subcutaneous adipocytes 3.01
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.97
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.97
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 2.95
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.94
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.89
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.89
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.89
Gene expression in GBM with Cav3.2 inhibition 2.86
2.85
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.83
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.83
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.82
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 2.82
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.82
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.81
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.81
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.79
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.79
mRNA expression profile of Lymphocytes 2.78
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.76
Effect of PBK knockdown on C4-2 cell transcriptome 2.75
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.74
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.72
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 2.72
The Genetic Landscape of Diamond-Blackfan Anemia 2.68
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.68
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.66
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.66
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.66
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.66
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.64
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.64
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.63
Transcriptomic analyssis following EHMT1/2 inhibition 2.61
Role of FGFR1 in neuronal devlopment 2.61
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.61
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.6
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.59
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.59
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.59
SLIGRL-induced gene expression changes in NHEK cells 2.54
Identification of HOXB13 target genes responsive to BET inhibitors 2.54
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.54
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.53
The cytokine environment influence on human skin-derived T cells 2.53
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.52
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.5
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.5
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.49
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.49
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.48
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.47
Dynamic 3D chromosomal landscapes in acute leukemia 2.45
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.45
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.44
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.44
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.4
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.38
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.38
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.34
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.34
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.34
DIGIT regulates endoderm differentiation of human embryonic stem cells 2.3
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.28
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.28
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.26
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.19
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.18
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.18
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 2.17
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.16
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.14
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.1
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 2.1
Characterization of human ILC2 subsets 2.09
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.07
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.07
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.06
Ribosome profiling upon inhibition of eIF4A 2.06
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.05
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.04
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.04
PRDM1 inhibits proliferation of human colon cancer organoids 2.0
Gene expression signatures of innate lymphoid cells from human blood 2.0
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.99
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.9
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.88
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.88
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.87
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.87
Functional significance of the HIV-1 Tat signature amino acid residues 1.86
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.85
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.82
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.79
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.77
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.77
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.76
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.76
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.75
Transcriptional profile in human S. haematobium infection 1.75
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.75
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.69
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.68
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.68
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.66
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.62
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.62
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.58
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.58
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.58
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.57
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.57
PTHrP overexpression in MCF7 cells 1.54
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.53
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.52
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.5
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.47
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.47
Ro60-knockout cells 1.46
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.45
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.42
Bone marrow derived human B cells [normal proB] 1.41
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.4
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.4
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.4
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.36
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.29
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.28
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.27
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.27
RNA-Seq from human ILC transitional populations 1.27
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.26
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.26
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.24
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.23
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.23
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.23
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.19
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.18
Human Treg NaCl stimulation 1.17
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.17
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.16
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 1.13
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.13
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.11
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.1
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.08
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.02
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.02
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.02
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.0
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.99
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.95
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.95
Human Treg IFNg/IL-10 subpopulations 0.93
6mer seed toxicity in tumour suppressive microRNAs 0.92
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.9
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.9
HNRNPM-regulated splicing dependencies in prostate cancer 0.9
Gene expression analysis upon mtDNA depletion 0.9
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.9
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.88
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.88
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.86
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.86
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.86
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.86
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.86
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.86
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.86
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.85
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.85
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.84
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.8
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.8
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.78
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.78
NHLRC1 re-expression in cancer cells 0.73
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.63
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.63
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.61
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.61
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.58
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.58
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.56
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.54
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.54
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.54
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.54
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.53
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.52
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.52
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.5
Exogenous rescue of KLHL9 in SF210 cell line 0.5
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.47
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.46
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.44
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.42
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.4
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.39
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.37
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.37
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.36
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.35
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.35
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.32
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.31
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.28
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.24
Human Treg IL-12 stimulation 0.24
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.23
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.23
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.23
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.21
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.21
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.2
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.19
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.19
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.16
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.16
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.14
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.13
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.13
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.13
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.12
Function and hormonal regulation of GATA3 in human first trimester placentation 0.11
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.1
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.09
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.09
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.09
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.07
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.07
Epigenomic conservation of transposable element silencing [RNA-seq] 0.07
Epigenomic conservation of transposable element silencing 0.07
The bromodomain protein BRD4 regulates splicing during heat shock 0.07
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.02
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.0
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation